Evidence map›Paper›PMID 35252079›Full record

ArticleFrontiers in public health

Incidence and Predictors of Imported Cases of COVID-19 in Burkina Faso.

Mikaila Kaboré, Kongnimissom Apoline Sondo, Désiré Lucien Dahourou, Yacouba Cissoko, Issa Konaté, Abdoulaye Zaré, Brice Bicaba, Boukary Ouedraogo, Hermann Barro, Eric Arnaud Diendéré and 10 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in public health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 63% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Effectiveness of international border control measures during the COVID-19 pandemic: a narrative synthesis of published systematic reviews.Philosophical transactions. Series A, Mathematical, physical, and engineering sciences · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 5 institutions in 3 countries.

Mikaila KaboréInfectious Diseases Department, Yalgado Ouedraogo Teaching Hospital, Ouagadougou, Burkina Faso.
Kongnimissom Apoline SondoInfectious Diseases Department, Yalgado Ouedraogo Teaching Hospital, Ouagadougou, Burkina Faso.
Désiré Lucien DahourouDepartment of Biomedical and Public Health, Research Institute of Health Sciences, Bobo Dioulasso, Burkina Faso.
Yacouba CissokoFaculty of Medicine and Odontostomatology, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali.
Issa KonatéFaculty of Medicine and Odontostomatology, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali.
Abdoulaye ZaréInfectious Diseases Department, Yalgado Ouedraogo Teaching Hospital, Ouagadougou, Burkina Faso.
Brice BicabaMinistry of Health, Ouagadougou, Burkina Faso.
Boukary OuedraogoMinistry of Health, Ouagadougou, Burkina Faso.
Hermann BarroMinistry of Health, Ouagadougou, Burkina Faso.
Eric Arnaud DiendéréTraining and Research Unit in Health Sciences, Joseph Ki-Zerbo University, Ouagadougou, Burkina Faso.
Isabella AsamoahInfectious Diseases Unit, Department of Medicine, Korle-Bu Teaching Hospital, Accra, Ghana.
Sandrine Nadège DamoueMinistry of Health, Ouagadougou, Burkina Faso.
Baperman Abdel Aziz SiriMinistry of Health, Ouagadougou, Burkina Faso.
Ismael DialloTraining and Research Unit in Health Sciences, Joseph Ki-Zerbo University, Ouagadougou, Burkina Faso.
Peter PuplampuInfectious Diseases Unit, Department of Medicine, Korle-Bu Teaching Hospital, Accra, Ghana.
Armel G PodaDepartment of Infectious Diseases, Souro Sanon Teaching Hospital, Bobo-Dioulasso, Burkina Faso.
Yacouba TolobaFaculty of Medicine and Odontostomatology, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali.
Sounkalo DaoFaculty of Medicine and Odontostomatology, University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali.
Martial OuédraogoTraining and Research Unit in Health Sciences, Joseph Ki-Zerbo University, Ouagadougou, Burkina Faso.
Seni KouandaDepartment of Biomedical and Public Health, Research Institute of Health Sciences, Bobo Dioulasso, Burkina Faso.
Université des Sciences, des Techniques et des Technologies de Bamako · MLCentre Hospitalier Universitaire Yalgado Ouédraogo · BFUniversité Joseph Ki-Zerbo · BFKorle Bu Teaching Hospital · GHWest African Health Organisation · BF

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTo limit the spread of COVID-19 due to imported cases, Burkina Faso has set up quarantine measures for arriving passengers. We aimed to determine the incidence and predictors of imported cases of COVID-19 in Burkina Faso.

methodsA prospective cohort study was performed using data from passengers arriving at the airport from April 9 to August 31, 2020. The data was extracted from the

resultsAmong 6,332 travelers who arrived in the study period, 173 imported cases (2.7%) were recorded. The incidence rate was 1.9 cases per 1,000 traveler-days (95%CI: 1.6-2.2 per 1,000). Passengers arriving in April (Adjusted hazard ratio [aHR] = 3.56; 95%CI: 1.62-7.81) and May (aHR = 1.92; 95% CI: 1.18-3.12) were more at risk of being tested positive compared to those arriving in August, as well as, passengers presenting with one symptom (aHR = 3.71; 95% CI: 1.63-8.43) and at least two symptoms (aHR = 10.82; 95% CI: 5.24-22,30) compared to asymptomatic travelers.

conclusionsThe incidence of imported cases was relatively low in Burkina Faso between April and August 2020. The period of travel and the presence of symptoms at arrival predicted the risk of being tested positive to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This is essential in the context of the high circulation of virus variants worldwide and the low local capacity to perform genotyping tests to strengthen the surveillance and screening capacities at the points of entry into the country.

Indexed as

COVID-19Burkina FasoHumansIncidenceProspective StudiesSARS-CoV-2Burkina FasoCOVID-19imported casesincidencepredictors

Identifiers

PMID35252079
PMCPMC8891149
OpenAlexW4213218268

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.